Responsiveness of the motor function measure in neuromuscular diseases

Archives of Physical Medicine and Rehabilitation

Volumn 93, Issue 12, 2012, Pages

  Vuillerot, Carole ^a,d,e,f   Payan, Christine ^b   Girardot, Françoise ^a   Fermanian, Jacques ^c   Iwaz, Jean ^a,d,e,f   Bérard, Carole ^a   Ecochard, René ^a,d,e,f  

^a HOSPICES CIVILS DE LYON   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITÉ DE LYON   (France)

^e UNIVERSITÉ LYON 1   (France)

^f LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

Author keywords

Chronic limitation of activity; Disability evaluation; Duchenne muscular dystrophy; Neuromuscular diseases; Outcome measures; Rehabilitation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CONVALESCENCE; DETERIORATION; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; FUNCTIONAL STATUS; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR FUNCTION MEASURE; MOTOR PERFORMANCE; MUSCULAR DYSTROPHY; MYOPATHY; MYOTONIC DYSTROPHY; NEUROMUSCULAR DISEASE; NEUROPATHY; OUTPATIENT; PHYSICIAN; PRESCHOOL CHILD; SCHOOL CHILD; SCORING SYSTEM; SPINAL MUSCULAR ATROPHY;

EID: 84869491156     PISSN: 00039993     EISSN: 1532821X     Source Type: Journal    
DOI: 10.1016/j.apmr.2012.05.025     Document Type: Article

References (35)

1. W.M. Fowler Jr, R.T. Abresch, S. Aitkens Profiles of neuromuscular diseases: design of the protocol Am J Phys Med Rehabil 74 1995 S62 S69
2. E. Scott, S.J. Mawson Measurement in Duchenne muscular dystrophy: considerations in the development of a neuromuscular assessment tool Dev Med Child Neurol 48 2006 540 544 (Pubitemid 43740921)
3. J. Montes, A.M. Gordon, S. Pandya, D.C. De Vivo, P. Kaufmann Clinical outcome measures in spinal muscular atrophy J Child Neurol 24 2009 968 978
4. D.M. Escolar, E.K. Henricson, J. Mayhew Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children Muscle Nerve 24 2001 787 793 (Pubitemid 32476525)
5. C. Berard, C. Payan, I. Hodgkinson, J. Fermanian A motor function measure for neuromuscular diseases: construction and validation study Neuromuscul Disord 15 2005 463 470 (Pubitemid 40884470)
6. E.S. Mazzone, S. Messina, G. Vasco Reliability of the North Star Ambulatory Assessment in a multicentric setting Neuromuscul Disord 19 2009 458 461
7. E. Mazzone, D. Martinelli, A. Berardinelli North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy Neuromuscul Disord 20 2010 712 716
8. E. Mercuri, S. Messina, R. Battini Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study Neuromuscul Disord 16 2006 93 98 (Pubitemid 43190740)
9. J. Fermanian [Validation of assessment scales in physical medicine and rehabilitation: how are psychometric properties determined?] Ann Readapt Med Phys 48 2005 281 287 (Pubitemid 40826357)
10. American Educational Research Association, American Psychological Association, & National Council of Measurement in Education Standards for educational and psychological testing 1999 American Educational Research Association Washington (DC)
11. C. Berard, J. Fermanian, C. Payan Outcome measure for SMA II and III patients Neuromuscul Disord 18 2008 593 594
12. D. Oeffinger, A. Bagley, S. Rogers Outcome tools used for ambulatory children with cerebral palsy: responsiveness and minimum clinically important differences Dev Med Child Neurol 50 2008 918 925
13. B. Kirshner, G. Guyatt A methodological framework for assessing health indices J Chronic Dis 38 1985 27 36 (Pubitemid 15136767)
14. G.H. Guyatt, R.A. Deyo, M. Charlson, M.N. Levine, A. Mitchell Responsiveness and validity in health status measurement: a clarification J Clin Epidemiol 42 1989 403 408 (Pubitemid 19165904)
15. J. Sloan, T. Symonds, D. Vargas-Chanes, B. Fridley Practical guidelines for assessing the clinical significance of health-related quality of life changes within clinical trials Clin Trials 37 2003 23 31 (Pubitemid 37305150)
16. B. Middel, E. van Sonderen Statistical significant change versus relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research Int J Integr Care 2 2002 e15
17. M.H. Brooke, R.C. Griggs, J.R. Mendell, G.M. Fenichel, J.B. Shumate Clinical trial in Duchenne dystrophy, 1: the design of the protocol Muscle Nerve 4 1981 186 197 (Pubitemid 11098499)
18. P.J. Vignos Jr, G.E. Spencer Jr, K.C. Archibald Management of progressive muscular dystrophy of childhood JAMA 184 1963 89 96
19. Y.J. Lue, R.F. Lin, S.S. Chen, Y.M. Lu Measurement of the functional status of patients with different types of muscular dystrophy Kaohsiung J Med Sci 25 2009 325 333
20. M. Main, H. Kairon, E. Mercuri, F. Muntoni The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation Eur J Paediatr Neurol 7 2003 155 159 (Pubitemid 36939996)
21. J.M. O'Hagen, A.M. Glanzman, M.P. McDermott An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients Neuromuscul Disord 17 2007 693 697 (Pubitemid 47362680)
22. O.M. Scott, S.A. Hyde, C. Goddard, V. Dubowitz Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy Muscle Nerve 5 1982 291 301 (Pubitemid 12070783)
23. B.F. Steffensen, S. Lyager, B. Werge, J. Rahbek, E. Mattsson Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study Dev Med Child Neurol 44 2002 623 632 (Pubitemid 34987636)
24. L. Vandervelde, P.Y. Van den Bergh, N. Goemans, J.L. Thonnard Activity limitations in patients with neuromuscular disorders: a responsiveness study of the ACTIVLIM questionnaire Neuromuscul Disord 19 2009 99 103
25. L. Vandervelde, P.Y. Van den Bergh, N. Goemans, J.L. Thonnard ACTIVLIM: a Rasch-built measure of activity limitations in children and adults with neuromuscular disorders Neuromuscul Disord 17 2007 459 469 (Pubitemid 46783448)
26. J. Cohen Statistical power analysis for the behavioral sciences 2nd ed. 1988 Erlbaum Hillsdale
27. C. Vuillerot, F. Girardot, C. Payan Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function Measure Dev Med Child Neurol 52 2010 60 65
28. S. Guinvarch, C. Bérard, P. Calmels Affections neuromusculaires F. Bethoux, P. Calmels, Guide des outils de mesure et d'évaluation en médecine physique et de réadaptation 2003 Frison-Roche Paris 269 283
29. R.T. Abresch, N.K. Seyden, M.A. Wineinger Quality of life: issues for persons with neuromuscular diseases Phys Med Rehabil Clin N Am 9 1998 233 248 (Pubitemid 28134029)
30. C. Vuillerot, I. Hodgkinson, A. Bissery Self-perception of quality of life by adolescents with neuromuscular diseases J Adol Health 46 2010 70 76
31. S.T. Iannaccone, B.S. Russman, R.H. Browne, C.R. Buncher, M. White, F.J. Samaha DCN/Spinal Muscular Atrophy Group Prospective analysis of strength in spinal muscular atrophy J Child Neurol 15 2000 97 101 (Pubitemid 30139873)
32. C.M. McDonald, E.K. Henricson, J.J. Han The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy Muscle Nerve 41 2010 500 510
33. J. Montes, M.P. McDermott, W.B. Martens Muscle Study Group and the Pediatric Neuromuscular Clinical Research Network Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy Neurology 74 2010 833 838
34. D.A. Revicki, D. Cella, R.D. Hays, J.A. Sloan, W.R. Lenderking, N.K. Aaronson Responsiveness and minimal important differences for patient reported outcomes Health Qual Life Outcomes 4 2006 70 75
35. H.C. de Vet, C.B. Terwee, R.W. Ostelo, H. Beckerman, D.L. Knol, L.M. Bouter Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change Health Qual Life Outcomes 4 2006 54